American International Group’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-24,899
| Closed | -$71K | – | 3110 |
|
|
2023
Q1 | $71K | Buy |
24,899
+4,301
| +21% | +$12.3K | ﹤0.01% | 2608 |
|
|
2022
Q4 | $150K | Buy |
20,598
+4,386
| +27% | +$31.9K | ﹤0.01% | 2304 |
|
|
2022
Q3 | $131K | Buy |
16,212
+229
| +1% | +$1.85K | ﹤0.01% | 2399 |
|
|
2022
Q2 | $78K | Buy |
15,983
+2,338
| +17% | +$11.4K | ﹤0.01% | 2718 |
|
|
2022
Q1 | $323K | Sell |
13,645
-961
| -7% | -$22.7K | ﹤0.01% | 1971 |
|
|
2021
Q4 | $258K | Buy |
14,606
+23
| +0.2% | +$406 | ﹤0.01% | 2213 |
|
|
2021
Q3 | $411K | Buy |
14,583
+2,172
| +18% | +$61.2K | ﹤0.01% | 1990 |
|
|
2021
Q2 | $130 | Buy |
12,411
+2,485
| +25% | +$26 | ﹤0.01% | 2766 |
|
|
2021
Q1 | $117 | Buy |
9,926
+1,607
| +19% | +$19 | ﹤0.01% | 2636 |
|
|
2020
Q4 | $97 | Sell |
8,319
-238
| -3% | -$3 | ﹤0.01% | 2677 |
|
|
2020
Q3 | $68K | Buy |
8,557
+907
| +12% | +$7.21K | ﹤0.01% | 2736 |
|
|
2020
Q2 | $140K | Buy |
7,650
+169
| +2% | +$3.09K | ﹤0.01% | 2319 |
|
|
2020
Q1 | $89K | Buy |
7,481
+4,638
| +163% | +$55.2K | ﹤0.01% | 2378 |
|
|
2019
Q4 | $47K | Sell |
2,843
-24
| -0.8% | -$397 | ﹤0.01% | 2896 |
|
|
2019
Q3 | $19K | Buy |
+2,867
| New | +$19K | ﹤0.01% | 3026 |
|